Functional analysis via standardized whole-blood stimulation systems defines the boundaries of a healthy immune response to complex stimuli.

Standardization of immunophenotyping procedures has become a high priority. We have developed a suite of whole-blood, syringe-based assay systems that can be used to reproducibly assess induced innate or adaptive immune responses. By eliminating preanalytical errors associated with immune monitoring, we have defined the protein signatures induced by (1) medically relevant bacteria, fungi, and viruses; (2) agonists specific for defined host sensors; (3) clinically employed cytokines; and (4) activators of T cell immunity. Our results provide an initial assessment of healthy donor reference values for induced cytokines and chemokines and we report the failure to release interleukin-1α as a common immunological phenotype. The observed naturally occurring variation of the immune response may help to explain differential susceptibility to disease or response to therapeutic intervention. The implementation of a general solution for assessment of functional immune responses will help support harmonization of clinical studies and data sharing.

[1]  Holden T. Maecker,et al.  Erratum: Standardizing immunophenotyping for the Human Immunology Project , 2012, Nature Reviews Immunology.

[2]  Patrik Edén,et al.  Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Rigau,et al.  Interferon-γ Release Assays for the Diagnosis of Tuberculosis and Tuberculosis Infection in HIV-Infected Adults: A Systematic Review and Meta-Analysis , 2012, PloS one.

[4]  R. Wunderink,et al.  Comparative in vitro stimulation with lipopolysaccharide to study TNFalpha gene expression in fresh whole blood, fresh and frozen peripheral blood mononuclear cells. , 2010, Journal of immunological methods.

[5]  Osamu Takeuchi,et al.  Cell type-specific involvement of RIG-I in antiviral response. , 2005, Immunity.

[6]  E. Soppi,et al.  A new micromethod for lymphocyte stimulation using whole blood. , 1975, Immunological communications.

[7]  Douglas T. Golenbock,et al.  Relationship between Structures and Biological Activities of Mycoplasmal Diacylated Lipopeptides and Their Recognition by Toll-Like Receptors 2 and 6 , 2004, Infection and Immunity.

[8]  Alistair J. P. Brown,et al.  Candida albicans morphogenesis and host defence: discriminating invasion from colonization , 2011, Nature Reviews Microbiology.

[9]  D. Jarrossay,et al.  Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β , 2012, Nature.

[10]  Shizuo Akira,et al.  Shared and Unique Functions of the DExD/H-Box Helicases RIG-I, MDA5, and LGP2 in Antiviral Innate Immunity1 , 2005, The Journal of Immunology.

[11]  Jun Ma,et al.  Activation of the innate immune receptor Dectin-1 upon formation of a “phagocytic synapse” , 2011, Nature.

[12]  I. Julkunen,et al.  Live Lactobacillus rhamnosus and Streptococcus pyogenes differentially regulate Toll‐like receptor (TLR) gene expression in human primary macrophages , 2008, Journal of leukocyte biology.

[13]  K. Ishii,et al.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.

[14]  R. Terkeltaub,et al.  TLR2 Signaling in Chondrocytes Drives Calcium Pyrophosphate Dihydrate and Monosodium Urate Crystal-Induced Nitric Oxide Generation1 , 2005, The Journal of Immunology.

[15]  P. Österlund,et al.  Multiple signaling pathways contribute to synergistic TLR ligand‐dependent cytokine gene expression in human monocyte‐derived macrophages and dendritic cells , 2009, Journal of leukocyte biology.

[16]  S. Akira,et al.  Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. , 2004, Blood.

[17]  Gunther Hartmann,et al.  T Cell-Independent, TLR-Induced IL-12p70 Production in Primary Human Monocytes1 , 2006, The Journal of Immunology.

[18]  Margarida Saraiva,et al.  The regulation of IL-10 production by immune cells , 2010, Nature Reviews Immunology.

[19]  B. Williams,et al.  Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .

[20]  S. Akira,et al.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 , 2001, Nature.

[21]  Keith T. Wilson,et al.  Helicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk , 2010, Clinical Microbiology Reviews.

[22]  S. Akira,et al.  Toll-like receptors. , 2003, Annual review of immunology.

[23]  H. Wagner,et al.  Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 , 2002, Nature Immunology.

[24]  K. Yokota,et al.  Helicobacter pylori heat-shock protein 60 induces interleukin-8 via a Toll-like receptor (TLR)2 and mitogen-activated protein (MAP) kinase pathway in human monocytes. , 2007, Journal of medical microbiology.

[25]  P. Brennan,et al.  CD1-restricted T cell recognition of microbial lipoglycan antigens. , 1995, Science.

[26]  L. Platanias.  Mechanisms of type-I- and type-II-interferon-mediated signalling , 2005, Nature Reviews Immunology.

[27]  P. Capel,et al.  Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human T cells , 1983, Nature.

[28]  D. Golenbock,et al.  Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. , 1999, Journal of immunology.

[29]  J Wagner,et al.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. , 2000, Immunity.

[30]  C. Dinarello.  Keep up the heat on IL-1. , 2012, Blood.

[31]  L. Miller,et al.  Host-pathogen interactions between the skin and Staphylococcus aureus. , 2012, Current opinion in microbiology.

[32]  G. Granger,et al.  Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[33]  H. Nishiyama,et al.  Bacillus Calmette–Guerin (BCG) immunotherapy for bladder cancer: Current understanding and perspectives on engineered BCG vaccine , 2013, Cancer science.

[34]  M. David,et al.  Immunomodulatory functions of type I interferons , 2012, Nature Reviews Immunology.

[35]  P. Haslett,et al.  A whole blood assay to assess peripheral blood dendritic cell function in response to Toll-like receptor stimulation. , 2006, Journal of immunological methods.

[36]  D. de Groote,et al.  Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. , 1992, Cytokine.

[37]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[38]  M. Otto.  Staphylococcus epidermidis — the 'accidental' pathogen , 2009, Nature Reviews Microbiology.

[39]  R. Peek,et al.  Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. , 2004, The Journal of infectious diseases.

[40]  Richard D. Wells,et al.  Association of Human TLR1 and TLR6 Deficiency with Altered Immune Responses to BCG Vaccination in South African Infants , 2011, PLoS pathogens.

[41]  A. Krieg,et al.  CpG motifs in bacterial DNA and their immune effects. , 2002, Annual review of immunology.

[42]  C. Josenhans,et al.  Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5. , 2003, Microbes and infection.

[43]  Shizuo Akira,et al.  Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.

[44]  M. Bennish,et al.  Interleukin‐1β (IL‐1β), IL‐1 receptor antagonist, and TNFα production in whole blood , 1992 .

[45]  E. Norrby,et al.  Humanized animal viruses with special reference to the primate adaptation of morbillivirus. , 1992, Veterinary microbiology.

[46]  D. Young,et al.  Mycobacterium bovis bacille Calmette Guerin infection of human neutrophils induces CXCL8 secretion by MyD88‐dependent TLR2 and TLR4 activation , 2005, Cellular microbiology.

[47]  T. Watanabe,et al.  Mycoplasma salivarium induces interleukin-6 and interleukin-8 in human gingival fibroblasts. , 1997, FEMS immunology and medical microbiology.

[48]  J. Ceuppens,et al.  Failure of OKT3 monoclonal antibody to induce lymphocyte mitogenesis: a familial defect in monocyte helper function. , 1985, Journal of immunology.

[49]  I. Kleinschmidt.  South African tuberculosis mortality data--showing the first sign of the AIDS epidemic? , 1999, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[50]  E. Chan,et al.  α‐1‐Antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood , 2009, Journal of leukocyte biology.

[51]  Min Zhang,et al.  TLR2 Mediates Helicobacter pylori–Induced Tolerogenic Immune Response in Mice , 2013, PloS one.

[52]  F. Marcucci,et al.  Induction of interferon gamma in leucocyte cultures of the peripheral blood of mice. , 1983, Journal of interferon research.

[53]  S. Akira,et al.  Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.

[54]  M. Netea,et al.  Regulation of Staphylococcus epidermidis-induced IFN-gamma in whole human blood: the role of endogenous IL-18, IL-12, IL-1, and TNF. , 2003, Cytokine.

[55]  M. Netea,et al.  Differential Roles of Interleukin-18 (IL-18) and IL-12 for Induction of Gamma Interferon by Staphylococcal Cell Wall Components and Superantigens , 2001, Infection and Immunity.

[56]  Wei Lu,et al.  T-cell activation , 1995 .

[57]  T. Cullen,et al.  Helicobacter pylori versus the Host: Remodeling of the Bacterial Outer Membrane Is Required for Survival in the Gastric Mucosa , 2011, PLoS pathogens.

[58]  M. Bennish,et al.  Interleukin-1 beta (IL-1 beta), IL-1 receptor antagonist, and TNF alpha production in whole blood. , 1992, Journal of leukocyte biology.

[59]  T. Hurst,et al.  Validation of a new highly standardised, lab-independent whole-blood leukocyte function assay for clinical trials (ILCS®) , 2004, Experimental Gerontology.

[60]  S. Gordon,et al.  Dectin-1 Mediates the Biological Effects of β-Glucans , 2003, The Journal of experimental medicine.

[61]  A. Pawłowski,et al.  Mycobacterium tuberculosis lipoarabinomannan enhances LPS-induced TNF-α production and inhibits NO secretion by engaging scavenger receptors. , 2011, Microbial pathogenesis.

[62]  M. Bennett,et al.  Intracellular Interleukin-1 Receptor 2 Binding Prevents Cleavage and Activity of Interleukin-1α, Controlling Necrosis-Induced Sterile Inflammation , 2013, Immunity.

[63]  O. Beretta,et al.  Gene Expression Profiles Identify Inflammatory Signatures in Dendritic Cells , 2010, PloS one.

[64]  K. Abbink,et al.  24 , 1871, You Can Cross the Massacre on Foot.

[65]  S. Foster,et al.  An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid , 2003, Nature Immunology.

[66]  M. Newport,et al.  Genetic regulation of immune responses to vaccines in early life , 2004, Genes and Immunity.

[67]  Jos W. M. van der Meer,et al.  Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases , 2012, Nature Reviews Drug Discovery.

[68]  Ulisses Braga-Neto,et al.  From Functional Genomics to Functional Immunomics: New Challenges, Old Problems, Big Rewards , 2006, PLoS Comput. Biol..

[69]  H. Schrezenmeier,et al.  T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells , 1988, The Journal of experimental medicine.

[70]  C. Dinarello,et al.  Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.

[71]  Shizuo Akira,et al.  Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2 , 2003, The Journal of experimental medicine.

[72]  B. Williams,et al.  Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[73]  Akiko Iwasaki,et al.  Inflammasome recognition of influenza virus is essential for adaptive immune responses , 2009, The Journal of experimental medicine.

[74]  J. Ting,et al.  The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. , 2009, Immunity.

[75]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[76]  H. Järvinen,et al.  Outbreak of diarrhoea due to Escherichia coli 0111:B4 in schoolchildren and adults: association of Vi antigen-like reactivity , 1990, The Lancet.

[77]  K. Huygen,et al.  An update on vaccines for tuberculosis – there is more to it than just waning of BCG efficacy with time , 2012, Expert opinion on biological therapy.

[78]  C. March,et al.  Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs , 1985, Nature.

[79]  島津 倫太郎.  MD-2,a molecule that confers lipopolysaccharide responsiveness on toll-like receptor 4 , 1999 .

[80]  H. Kirchner,et al.  A whole-blood technique for testing production of human interferon by leukocytes. , 1982, Journal of immunological methods.

[81]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[82]  Joshua M. Korn,et al.  The plasticity of dendritic cell responses to pathogens and their components. , 2001, Science.

[83]  J. Schmitz,et al.  24. Clinical and laboratory assessment of immunity. , 2003, The Journal of allergy and clinical immunology.

[84]  F. Martinon,et al.  Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.

[85]  B. Pulendran,et al.  Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates. , 2012, Blood.

[86]  邊見 弘明,et al.  A Toll-like receptor recognizes bacterial DNA , 2003 .

[87]  W. Hammes,et al.  Safety of probiotics that contain lactobacilli or bifidobacteria. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.